NO20090027L - Ny analog av vasoaktivt tarmpeptid - Google Patents

Ny analog av vasoaktivt tarmpeptid

Info

Publication number: NO20090027L
Authority: NO; Norway
Prior art keywords: vasoactive intestinal; intestinal peptide; new analog; analog; new
Prior art date: 2006-07-06

Application number

NO20090027A

Other languages

English (en)

Norwegian (no)

Inventor

David Robert Bolin

Wajiha Khan

Hanspeter Michel

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-07-06

Filing date

2009-01-05

Publication date

2009-01-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38786842&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20090027(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-01-05 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2009-01-15 Publication of NO20090027L publication Critical patent/NO20090027L/no

Links

102000055135 Vasoactive Intestinal Peptide Human genes 0.000 title 1
108010003205 Vasoactive Intestinal Peptide Proteins 0.000 title 1
VBUWHHLIZKOSMS-RIWXPGAOSA-N invicorp Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=C(O)C=C1 VBUWHHLIZKOSMS-RIWXPGAOSA-N 0.000 title 1
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 abstract 1
102100038286 Vasoactive intestinal polypeptide receptor 2 Human genes 0.000 abstract 1
101710137651 Vasoactive intestinal polypeptide receptor 2 Proteins 0.000 abstract 1
230000000414 obstructive effect Effects 0.000 abstract 1
230000002685 pulmonary effect Effects 0.000 abstract 1
239000000018 receptor agonist Substances 0.000 abstract 1
229940044601 receptor agonist Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Endocrinology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Toxicology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Vascular Medicine (AREA)
Rheumatology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

NO20090027A 2006-07-06 2009-01-05 Ny analog av vasoaktivt tarmpeptid NO20090027L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US81880506P	2006-07-06	2006-07-06
PCT/EP2007/056351 WO2008003612A2 (en)	2006-07-06	2007-06-26	Analogs of vasoactive intestinal peptide

Publications (1)

Publication Number	Publication Date
NO20090027L true NO20090027L (no)	2009-01-15

Family

ID=38786842

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20090027A NO20090027L (no)	2006-07-06	2009-01-05	Ny analog av vasoaktivt tarmpeptid

Country Status (20)

Country	Link
US (1)	US20080096807A1 (es)
EP (1)	EP2041168A2 (es)
JP (1)	JP2009542593A (es)
KR (1)	KR20090027239A (es)
CN (1)	CN101484468A (es)
AR (1)	AR061825A1 (es)
AU (1)	AU2007271274A1 (es)
BR (1)	BRPI0714306A2 (es)
CA (1)	CA2656757A1 (es)
CL (1)	CL2007001956A1 (es)
CR (1)	CR10518A (es)
EC (1)	ECSP099029A (es)
IL (1)	IL196122A0 (es)
MA (1)	MA30590B1 (es)
MX (1)	MX2009000013A (es)
NO (1)	NO20090027L (es)
PE (1)	PE20081000A1 (es)
RU (1)	RU2009103811A (es)
TW (1)	TW200819139A (es)
WO (1)	WO2008003612A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2011245980A1 (en)	2010-04-30	2012-11-08	Sanwa Kagaku Kenkyusho Co., Ltd.	Peptide for improving in vivo stability of physiologically active substance or the like and physiologically active substance with improved in vivo stability
CN102827268B (zh) *	2011-06-13	2016-08-24	中肽生化有限公司	新型血管肠肽类似物及其制备方法和用途
US8866872B2 (en)	2011-06-21	2014-10-21	Mitel Networks Corporation	Conferencing and collaboration system and methods thereof
EP2968469A4 (en) *	2013-03-15	2016-08-31	Longevity Biotech Inc	PEPTIDES COMPRISING NON-ENDOGENIC AMINO ACIDS AND METHODS OF MAKING AND USING SAME
EP3139949B1 (en) *	2014-05-08	2020-07-29	Phasebio Pharmaceuticals, Inc.	Compositions comprising a vip-elp fusion protein for use in treating cystic fibrosis
ITUB20159175A1 (it) *	2015-12-23	2017-06-23	Materie Plastiche Pisane S R L	Composizione polimerica antibatterica

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3879371A (en) *	1971-09-17	1975-04-22	Sami I Said	Isolation of vasoactive intestinal peptide
GB8427651D0 (en) *	1984-11-01	1984-12-05	Beecham Group Plc	Compounds
GB8525852D0 (en) *	1985-10-19	1985-11-20	Beecham Group Plc	Compounds
JPS62246595A (ja) *	1986-04-17	1987-10-27	Eisai Co Ltd	気菅支拡張作用・降圧作用ペプタイド
US4835252A (en) *	1987-02-26	1989-05-30	The Salk Institute Biotechnology/Industrial Associates, Inc.	Vasoactive intestinal peptide analogs
AU656230B2 (en) *	1991-10-11	1995-01-27	F. Hoffmann-La Roche Ag	Cyclic vasoactive peptides
EP0879246B1 (en) *	1996-02-09	2006-05-31	F. Hoffmann-La Roche Ag	Synthesis of vip analog
US20050203009A1 (en) *	2004-03-12	2005-09-15	Bayer Pharmaceuticals Corporation	VPAC1 selective antagonists and their pharmacological methods of use
CA2576755A1 (en) *	2004-08-18	2006-03-02	Eli Lilly And Company	Selective vpac2 receptor peptide agonists
JP2008515437A (ja) *	2004-10-08	2008-05-15	フォーブスメディ−テック（リサーチ）インコーポレーテッド	血管活性腸管ポリペプチド医薬品

2007
- 2007-06-26 JP JP2009517165A patent/JP2009542593A/ja active Pending
- 2007-06-26 EP EP07765625A patent/EP2041168A2/en not_active Withdrawn
- 2007-06-26 MX MX2009000013A patent/MX2009000013A/es not_active Application Discontinuation
- 2007-06-26 CA CA002656757A patent/CA2656757A1/en not_active Abandoned
- 2007-06-26 CN CNA2007800254947A patent/CN101484468A/zh active Pending
- 2007-06-26 BR BRPI0714306-0A patent/BRPI0714306A2/pt not_active IP Right Cessation
- 2007-06-26 KR KR1020097000221A patent/KR20090027239A/ko not_active Ceased
- 2007-06-26 AU AU2007271274A patent/AU2007271274A1/en not_active Abandoned
- 2007-06-26 WO PCT/EP2007/056351 patent/WO2008003612A2/en not_active Ceased
- 2007-06-26 RU RU2009103811/10A patent/RU2009103811A/ru unknown
- 2007-07-03 US US11/825,105 patent/US20080096807A1/en not_active Abandoned
- 2007-07-04 TW TW096124342A patent/TW200819139A/zh unknown
- 2007-07-05 CL CL200701956A patent/CL2007001956A1/es unknown
- 2007-07-05 AR ARP070102996A patent/AR061825A1/es unknown
- 2007-07-05 PE PE2007000873A patent/PE20081000A1/es not_active Application Discontinuation
2008
- 2008-12-17 CR CR10518A patent/CR10518A/es not_active Application Discontinuation
- 2008-12-22 IL IL196122A patent/IL196122A0/en unknown
2009
- 2009-01-05 EC EC2009009029A patent/ECSP099029A/es unknown
- 2009-01-05 NO NO20090027A patent/NO20090027L/no not_active Application Discontinuation
- 2009-01-13 MA MA31568A patent/MA30590B1/fr unknown

Also Published As

Publication number	Publication date
AU2007271274A1 (en)	2008-01-10
WO2008003612A2 (en)	2008-01-10
AR061825A1 (es)	2008-09-24
ECSP099029A (es)	2009-02-27
CL2007001956A1 (es)	2008-04-18
CN101484468A (zh)	2009-07-15
RU2009103811A (ru)	2010-08-20
MX2009000013A (es)	2009-01-23
WO2008003612A3 (en)	2008-02-28
EP2041168A2 (en)	2009-04-01
CR10518A (es)	2009-01-27
TW200819139A (en)	2008-05-01
IL196122A0 (en)	2011-08-01
PE20081000A1 (es)	2008-08-06
CA2656757A1 (en)	2008-01-10
JP2009542593A (ja)	2009-12-03
US20080096807A1 (en)	2008-04-24
KR20090027239A (ko)	2009-03-16
MA30590B1 (fr)	2009-07-01
BRPI0714306A2 (pt)	2014-05-20

Publication	Publication Date	Title
WO2008149150A3 (en)	2009-06-25	Polypeptides, antibody variable domains and antagonists
NO20090027L (no)	2009-01-15	Ny analog av vasoaktivt tarmpeptid
WO2008149147A3 (en)	2009-06-11	Polypeptides, antibody variable domains and antagonists
CY1121543T1 (el)	2020-05-29	Ενωση πυριδυλαμινοοξεικου οξεος
WO2008149144A3 (en)	2009-04-02	Polypeptides, antibody variable domains and antagonists
WO2008051942A3 (en)	2008-07-03	Farnesoid x receptor agonists
MX2009013990A (es)	2010-03-30	Metodos para tratar enfermedades y trastornos mediados por serotonina.
TW200738632A (en)	2007-10-16	Cannabinoid receptor modulators
WO2010042543A3 (en)	2011-08-11	Use of inhibitors of toll-like receptors in the prevention and treatment of hypercholesterolemia and hyperlipidemia and diseases related thereto
WO2006117299A3 (en)	2007-02-22	Novel crystalline forms of tiotropium bromide
MX2009001534A (es)	2009-04-08	Preparacion de (r,r)-fenoterol y analogos de (r,r)- o (r,s)-fenoterol y su uso en el tratamiento de insuficiencia cardiaca congestiva.
WO2007076260A3 (en)	2007-11-01	Farnesoid x receptor agonists
MX2011008799A (es)	2011-09-27	Polipeptidos, dominios variables de anticuerpos, y antagonistas anti-tnfr1 mejorados.
WO2012110770A3 (en)	2012-10-04	Combination of glycopyrrolate and a beta2 -agonist
MY147442A (en)	2012-12-14	Imidazoquinolines as lipid kinase inhibitors
WO2008070111A3 (en)	2008-08-07	Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
WO2009036175A3 (en)	2009-05-07	F1f0-atpase inhibitors and related methods
WO2010149578A3 (en)	2011-07-14	Novel biphenyl and phenyl-pyridine amides
WO2009053339A3 (en)	2010-06-17	Cholesterol derivatives of inhibitors of viral fusion
WO2010048477A3 (en)	2011-02-24	Improved process for preparation of coupled products from 4-amino-3-cyanoquinolines using stabilized intermediates
MX2009007911A (es)	2009-07-31	Inhibidores de proteina tirosina fosfatasa 1b aromaticos fusionados.
WO2006117300A3 (en)	2007-04-26	Crystalline forms of tiotropium bromide
NO20091741L (no)	2009-05-29	Pyrazolinforbindelser som mineralkortikoidreceptorantagonister
WO2009025785A3 (en)	2009-09-11	Cb2 receptor ligands for the treatment of pain
MY162095A (en)	2017-05-31	Method of treating symptoms of hormonal variations

Legal Events

Date	Code	Title	Description
2013-02-04	FC2A	Withdrawal, rejection or dismissal of laid open patent application